Community Pharmacy Committed to Safe U.S. Drug Supply Chain, NACDS Tells House Panel

Published Online: Thursday, March 27, 2014
Follow Pharmacy_Times:
PRESS RELEASE

March 27, 2014, Arlington, Va. Emphasizing its commitment to a safe supply chain for prescription drugs, the National Association of Chain Drug Stores (NACDS) expressed support for the leadership and efforts of Congress and the Food and Drug Administration (FDA) in taking commonsense approaches in safeguarding the process of delivering prescription medications to patients.

NACDS submitted a statement in lead-up to today’s hearing by the U.S. House of Representatives Committee on Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee titled, “Budget Hearing – Food and Drug Administration.”

In its statement, NACDS cited pharmacy’s work to help shape the Drug Quality and Security Act, its ongoing advocacy and engagement in the implementation of the new law, and its long-term efforts to safeguard the drug distribution supply chain.

“Chain pharmacies wholeheartedly support efforts to secure the U.S. drug distribution supply chain. They have invested significant resources and efforts towards this goal over many years, including changes in their purchasing practices, and actively supporting state legislation that strengthened supply chain integrity,” NACDS said in its statement.

NACDS also stressed the need to address the problem of illegitimate Internet drug sellers to help protect U.S. consumers from counterfeit and adulterated medications, and recognized FDA’s efforts to educate consumers and healthcare providers about the risks of illegal online drug sellers.

“We support targeting illegal Internet drug sellers through the chokepoint approach. Under this approach, Internet service entities and companies such as domain name registrars that issue websites, financial entities that handle payment transactions for online sales, Internet Service Providers that provide information from the Internet, and common carriers that provide the mailing services would have authority to stop illicit transactions at their point of interaction with these bad actors,” NACDS said in its statement.

NACDS also urged Congress and the FDA to provide an Internet portal so that consumers and healthcare providers would have the ability to check if an online website offering to sell medications is legitimate.

In its statement, the association urged Congress to provide the FDA with requisite funding necessary to establish an abbreviated approval pathway for biosimilars and interchangeable versions of biological products.

“For the benefit of the patients we serve, we have urged the agency to make establishing this pathway among its highest priorities. Increasing generic drug utilization is one of the most effective ways to control healthcare costs,” NACDS said in its statement.

“We believe that the U.S. supply chain is one of the safest, if not the safest, in the world. The strength and commitment of chain pharmacies and other U.S. supply chain stakeholders are key components in helping achieve this security,” NACDS said in its statement.
Related Articles
Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to today’s hearing titled “Examining Public Health Legislation to Help Patients and Local Communities.”
The Alliance for Safe Online Pharmacies and the Federation of State Medical Boards announce the availability of a free online continuing education program, entitled “Internet Drug Sellers: What Providers Need To Know” for pharmacists and physicians focused on the growing problem of illegal online drug sales.
In support of pharmacy refill reminder programs and other healthcare communications by pharmacies, the National Association of Chain Drug Stores recently filed comments with the Federal Communications Commission requesting regulatory clarification regarding prior consent for calls to consumers’ cell phones for healthcare notifications.
Legislation to help curb prescription drug diversion and abuse and protect patients in need of medications received support from the National Association of Chain Drug Stores this week.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$